The effect of telithromycin on inflammatory markers in chronic obstructive pulmonary diseases

European Journal of General Medicine

Volumn 6, Issue 4, 2009, Pages 218-222

  Bekçi, Taha ^a   Kurtipek, Ercan ^a   Kesli, Recep ^a   Maden, Emin ^b   Teke, Turgut ^b  

^a KONYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Chronic obstructive pulmonary diseases; Interleukin 8; Myeloperoxidase; Telithromycin; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 8; MYELOPEROXIDASE; PLACEBO; SALBUTAMOL; TELITHROMYCIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTERIAL GAS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL INTOLERANCE; HUMAN; LABORATORY TEST; LUNG FUNCTION TEST; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; SPUTUM ANALYSIS; SPUTUM LEVEL; STOMACH DISCOMFORT; TREATMENT DURATION; TREATMENT RESPONSE; VAGINITIS;

EID: 74849093667     PISSN: 13043889     EISSN: None     Source Type: Journal    
DOI: 10.29333/ejgm/82673     Document Type: Article

References (10)

1. Banerjee D, Khair OA, Honeybourne D.The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD. Respir Med 2005; 99: 208-15.
2. Garey KW, Rubinstein I, Gotfried MH, Khan IJ, Varma S, Danzige LH. Long-term claritromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma. Chest 2000; 118: 1826-7.
3. Beeh KM, Kornmann O, Buhl R, Culpitt Sv, Giembycz MA, Barnes PJ. Neutrophil chemotactic activity of sputum from patients with CPOD: role of interleukin-8 and leukotrien B4. Chest 2003; 123: 1240-7.
4. Global Initiative for Chronic Obstructive Diseases. Global strategy for diagnosis, management and prevention of chronic obstructive pulmonary diseases. NHLBI/ WHO Workshop Report, July 2003.
5. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-9.
6. Diamant Z, Grootendorst DC, Veselic-Charvat M, et al. The effects of montelulast (MK-0476), a cysteinyl leukotriene receptor antagonist, an allergen-induced airways responses and sputum cell counts in asthma. Clin Exp Allergy 1999; 29: 42-51.
7. Popov T, Gottschalk R, Kolendowicz R, Dolovic J, Powers P, Hargreave FE. The evaluation of cell dispersion method of sputum examination. Clin Exp Allergy 1994; 24: 778-83.
8. Culic O, Erakovic V, Cepelak I, et al. Azitromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. European Journal of Pharmacolgy2002; 450: 277-89.
9. Macleod CM, Hamid QA, Cameron L, Treamblay C, Brisco W. Anti-inflamatory activity of claritromycin in adults with chronically inflamed sinus mucusa. Adv Ther 2001; 18: 75-82.
10. Wellington K, Noble S. Telithromycin. Drugs 2004; 64: 1683-94; 1695-6.